$746 Million is the total value of HARBOURVEST PARTNERS LLC's 44 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| W | New | Wayfair, Inc. | $334,304,000 | – | 1,062,126 | +100.0% | 44.84% | – |
| SNOW | New | Snowflake Computing, Inc. | $72,964,000 | – | 318,233 | +100.0% | 9.79% | – |
| NARI | New | Inari Medical | $15,780,000 | – | 147,475 | +100.0% | 2.12% | – |
| RBLX | New | Roblox Corporation | $14,105,000 | – | 217,569 | +100.0% | 1.89% | – |
| RLAY | New | Relay Therapeutics, Inc. | $10,247,000 | – | 296,402 | +100.0% | 1.37% | – |
| IBRX | New | ImmunityBio, Inc. | $8,238,000 | – | 347,009 | +100.0% | 1.10% | – |
| EB | New | Eventbrite, Inc. | $8,212,000 | – | 370,564 | +100.0% | 1.10% | – |
| DDOG | New | Datadog, Inc. | $7,764,000 | – | 93,162 | +100.0% | 1.04% | – |
| TWLO | New | Twilio, Inc. | $4,966,000 | – | 14,572 | +100.0% | 0.67% | – |
| DASH | New | DoorDash, Inc. | $3,921,000 | – | 29,903 | +100.0% | 0.53% | – |
| CRWD | New | CrowdStrike Holdings, Inc. | $2,496,000 | – | 13,676 | +100.0% | 0.34% | – |
| U | New | Unity Software | $2,197,000 | – | 21,899 | +100.0% | 0.30% | – |
| AFRM | New | Affirm, Inc. | $1,984,000 | – | 28,053 | +100.0% | 0.27% | – |
| PACB | New | Pacific Biosciences of California, Inc. | $782,000 | – | 23,484 | +100.0% | 0.10% | – |
| DCT | New | Duck Creek Technologies, Inc. | $655,000 | – | 14,508 | +100.0% | 0.09% | – |
| NET | New | CloudFlare, Inc. | $652,000 | – | 9,278 | +100.0% | 0.09% | – |
| OYST | New | Oyster Point Pharma, Inc. | $625,000 | – | 34,185 | +100.0% | 0.08% | – |
| SPT | New | Sprout Social, Inc. | $502,000 | – | 8,692 | +100.0% | 0.07% | – |
| New | Marinus Pharmaceuticals, Inc. | $479,000 | – | 30,962 | +100.0% | 0.06% | – | |
| FROG | New | Jfrog | $477,000 | – | 10,756 | +100.0% | 0.06% | – |
| RPTX | New | Repare Therapeutics, Inc. | $377,000 | – | 12,276 | +100.0% | 0.05% | – |
| RAPT | New | Rapt Therapeutics, Inc. | $274,000 | – | 12,351 | +100.0% | 0.04% | – |
| PMVP | New | PMV Pharmaceuticals | $253,000 | – | 7,692 | +100.0% | 0.03% | – |
| JNCE | New | Jounce Therapeutics, Inc. | $205,000 | – | 19,927 | +100.0% | 0.03% | – |
| AM | New | Antero Midstream GP | $30,000 | – | 3,316 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
| 13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.